Metabolic Reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy

被引:14
|
作者
Zhang, Ximing [1 ]
Chen, Mianrong [1 ]
Ni, Xiang [2 ]
Wang, Yingying [3 ]
Zheng, Xue [1 ]
Zhang, Hui [1 ]
Xu, Shi [2 ]
Yang, Chun-tao [1 ]
机构
[1] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou Municipal & Guangdong Prov Key Lab Prot, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
[3] Washington State Univ, Dept Chem, Pullman, WA 99164 USA
关键词
bioinformatics; hepatocellular carcinoma; metabolic reprogramming; reactive sulfur species; sulfane sulfur; HYDROGEN-SULFIDE; VITAMIN-B6; METABOLISM; CANCER; PROLIFERATION; BIOLOGY;
D O I
10.3389/fphar.2020.571143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolic reprogramming is a cancer hallmark. Although the reprogramming of central carbon has been well documented, the role of sulfur metabolism has been largely overlooked. Additionally, the effects of sulfur are sometimes contradictory in tumorigenesis. In this study, we aimed to investigate the gene expression profile in hepatocellular carcinoma (HCC) and the effects of reactive sulfur species (RSS) on HCC tumor cells. Furthermore, the cell imaging technology was applied to discover some potential anti-cancer compounds. Gene Set Enrichment Analysis (GSEA) of Gene Expression Omnibus (GEO) dataset (GSE102083) revealed that sulfur amino acid-related metabolism and vitamin B(6)binding activity in HCC tissues were downregulated. Calculation of the interaction network identified nine hub genes, among which eight were validated by differential expression and survival analysis in the TCGA_LIHC cohort, and two (CSE and CBS) had the highest enrichment degree. The metabolomics analysis suggested that the hub genes were associated with RSS metabolism including H2S, H2S2, cystine, cysteine, homocysteine, cystathionine, and methionine. The cell viability assay demonstrated that H(2)S(2)had significant anti-cancer effects in HCC SNU398 tumor cells. The cell imaging assay showed that treatment with H(2)S(2)remarkably increased intracellular sulfane sulfur content. On this basis, the anti-cancer activity of some other sulfane sulfur compounds, such as DATS and DADS, was further verified. Lastly, according to the fact that HCC tumor cells preferentially take in cystine due to high expression of SLC7A11 (a cystine/glutamate transporter), persulfided cysteine precursor (PSCP) was tested for its sulfane sulfur release capability and found to selectively inhibit HCC tumor cell viability. Collectively, this study uncovered sulfur metabolism in HCC was reprogrammed, and provided a potential therapeutic strategy for HCC by donating sulfane sulfur.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment
    Hirschfield, Hadassa
    Bian, C. Billie
    Higashi, Takaaki
    Nakagawa, Shigeki
    Zeleke, Tizita Z.
    Nair, Venugopalan D.
    Fuchs, Bryan C.
    Hoshida, Yujin
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : e419 - e419
  • [22] Potent anti-cancer effect of crocin against hepatocellular carcinoma: A preclinical study
    Amin, Amr
    Schneider-Stock, Regine
    Daoud, Sayel
    CANCER RESEARCH, 2012, 72
  • [23] Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma
    Ke, Weiwei
    Wang, Hongbo
    Zhao, Xiangxuan
    Lu, Zaiming
    FOOD & FUNCTION, 2021, 12 (04) : 1482 - 1497
  • [24] POTENTIAL ANTI-CANCER ACTIVITY OF PLATINUM AND PALLADIUM COMPLEXES WITH SULFUR-NITROGEN CHELATING LIGANDS
    KIRSCHNER, S
    MAURER, A
    DRAGULESCU, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1975, (169): : 161 - 161
  • [25] KIDNEY GLUTAMINASE IN HEPATOCELLULAR CARCINOMA: A NOVEL DRUGGABLE TARGET ADDRESSING CANCER CELL METABOLIC REPROGRAMMING
    Tambay, Vincent
    Raymond, Valerie-Ann
    Bilodeau, Marc
    HEPATOLOGY, 2023, 78 : S1941 - S1941
  • [26] ENHANCED GLUTAMINASE ACTIVITY IN HEPATOCELLULAR CARCINOMA: INSIGHT INTO A NOVEL UNDERSTANDING OF CANCER CELL METABOLIC REPROGRAMMING
    Tambay, Vincent
    Raymond, Valerie-Ann
    Bilodeau, Marc
    HEPATOLOGY, 2022, 76 : S1337 - S1337
  • [27] Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice
    Pornprom Yoysungnoen
    Ponthip Wirachwong
    Chatchawan Changtam
    Apichart Suksamrarn
    Suthiluk Patumraj
    World Journal of Gastroenterology, 2008, (13) : 2003 - 2009
  • [28] Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice
    Yoysungnoen, Pornprom
    Wirachwong, Ponthip
    Changtam, Chatchawan
    Suksamram, Apichart
    Patumraj, Suthiluk
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (13) : 2003 - 2009
  • [29] Iron depletion: A potential anti-cancer therapy for human hepatocellular carcinoma (an animal study).
    Hann, HWL
    Li, LL
    Feitelson, MA
    Clayton, MM
    Menduke, H
    HEPATOLOGY, 1996, 24 (04) : 891 - 891
  • [30] Anti-cancer Properties of New Curcumin Analogues Targets on Microtubule Arrangement in Hepatocellular Carcinoma
    Meiyanto, Edy
    Nugraheni, Nadzifa
    Zulfin, Ummi M.
    Lestari, Beni
    Hapsari, Novia P.
    Ikawati, Muthi
    Utomo, Rohmad Y.
    Suenaga, Yusuke
    Hippo, Yoshitaka
    CANCER SCIENCE, 2025, 116 : 1674 - 1674